CG Oncology (CGON) announced the publication in Nature Medicine of Phase 1b investigator-sponsored study results evaluating intravesical cretostimogene grenadenorepvec in combination with Bristol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback